Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
- 8 July 2008
- journal article
- practice guideline
- Published by Wiley in Haemophilia
- Vol. 14 (4), 671-684
- https://doi.org/10.1111/j.1365-2516.2008.01695.x
Abstract
Evidence-based guidelines are presented on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. They include details of therapeutic products available in the UK and they update and replace previous United Kingdom Haemophilia Centre Doctors' Organisation guidelines.Keywords
This publication has 46 references indexed in Scilit:
- The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ OrganizationHaemophilia, 2006
- Hemophilia Therapy and Blood-Borne Pathogen RiskSeminars in Thrombosis and Hemostasis, 2006
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors OrganisationBritish Journal of Haematology, 2006
- Haemostatic management of intraoral bleeding in patients with von Willebrand diseaseOral Diseases, 2005
- Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand diseaseBritish Journal of Haematology, 2004
- Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohortBritish Journal of Haematology, 2002
- Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrateThe Lancet, 1994
- Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrateBritish Journal of Haematology, 1993
- Myocardial Infarction in a Patient with Hemophilia Treated with dDAVPNew England Journal of Medicine, 1988
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983